Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients

Journal of Craniofacial Surgery

Volumn 22, Issue 5, 2011, Pages 1684-1688

  Rauso, Raffaele ^a   Curinga, Giuseppe ^b   Santillo, Vincenzo ^a   Corvo, Giovanni ^a   Tartaro, Gianpaolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Civico Hospital   (Italy)

Author keywords

Facial rehabilitation; Facial wasting; Lipodystrophy; Lipofilling; Nonabsorbable filler

Indexed keywords

ACRYLIC ACID RESIN; AQUAMID; BIOMATERIAL;

ADIPOSE TISSUE; ADULT; ARTICLE; COMPARATIVE STUDY; ESTHETIC SURGERY; ESTHETICS; FACE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROGEL; INJECTION; MALE; PROSPECTIVE STUDY; TRANSPLANTATION; TREATMENT OUTCOME;

ACRYLIC RESINS; ADIPOSE TISSUE; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOCOMPATIBLE MATERIALS; COSMETIC TECHNIQUES; ESTHETICS; FACE; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; HYDROGELS; INJECTIONS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80053466274     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e31822e5cf8     Document Type: Article

References (30)

1. Karon JM, Fleming PL, Steketee RW, et al. HIV in the United States at the turn of the century. Am J Public Health 2001;91:1060
2. Centers for Disease Control and Prevention. The global HIV/AIDS epidemic, 2001. MMWR Morb Mortal Wkly Rep 2001;50:430
3. Davison SP, Timpone J Jr, Hannan CM. Surgical algorithm for management of HIV lipodistrophy. Plast Reconstr Surg 2007;120:1843-1857
4. Moyle GJ, Brown S, Lysakova L, et al. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med 2006;7:181-185 (Pubitemid 43337597)
5. Mijch A, Bowtell-Harris C, Archer B, et al. Subcutaneous polylactic acid in HIV-1 associated facial lipoatrophy: clinical and spiral CT-scan outcome as predictors of response [abstract 851]. 12th Conference on Retroviruses and Opportunistic Infections; February 22-25, 2005; Boston, MA
6. James J, Carruthers A, Carruthers J. HIV-associated facial lipoatrophy. Dermatol Surg 2002;28:979-986 (Pubitemid 35424794)
7. Rauso R, Tartaro G, Cobellis G, et al. HIV-related lipoatrophy of the face: where should we have to fill? Plast Reconstr Surg 2011;127: 143e-144e
8. Carr AA. Syndrome of peripheral lipodistrophy, hyperlipidemia, and insulin resistance in patients on HIV protease inhibitors. AIDS 1998;12:F51
9. Schambelan M, Benson CA, Carr A, et al. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr 2002;31:257-275 (Pubitemid 35278626)
10. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-fill) to correct facial lipoatrophy in HIV-infected patients: results of the open study VEGA. AIDS 2003;17:2471-2477 (Pubitemid 38393319)
11. Amin SP, Marmur ES, Goldberg DJ. Complications from injectable polycrylamide gel, a new nonbiogradable soft tissue filler. Dermatol Surg 2004;30:1507-1509 (Pubitemid 40053511)
12. Sturm LP, Cooter RD, Mutimer KL, et al. A systematic review of permanent and semipermanent dermal fillers for HIV-associated facial lipoatrophy. AIDS Patient Care STDS 2009;23:699-714
13. Negredo E, Higueras C, Adell X, et al. Reconstructive treatment for antiretroviral-associated lipoatrophy: a prospective study comparing autologous fat and synthetic substances. AIDS Patient Care STDS 2006;12:829-837 (Pubitemid 46106070)
14. Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg 1997;24:347
15. Coleman SR. Hand rejuvenation with structural fat grafting. Plast Reconstr Surg 2002;11:1731
16. Ersek RA. Transplantation of purified autologous fat: a 3-year follow-up is disappointing. Plast Reconstr Surg 1991;87:219-227
17. Serra-Renom JM, Fontdevila J. Treatment of facial atrophy related to treatment with protease inhibitors by autologous fat injection in patients with human immunodeficiency virus infection. Plast Reconstr Surg 2004;114:551-555 (Pubitemid 39201666)
18. Coleman SR. Long-term survival of fat transplants: controlled demonstrations. Aesthetic Plast Surg 1995;19:421-425
19. Guerrerosantos J. Long-term outcome of autologous fat transplantation in aesthetic facial recontouring: sixteen years of experience with 1936 cases. Clin Plast Surg 2000;27:515-543
20. Coleman SR. Facial augmentation with structural fat grafting. Clin Plast Surg 2006;33:567-577 (Pubitemid 44679715)
21. Nelson L, Stewart KJ. Experience in the treatment of HIV-associated lipodystrophy. J Plast Reconstr Aesthet Surg 2008;61:366-371 (Pubitemid 351389378)
22. Gatt JE. Permanent lip augmentation with serial fat grafting. Ann Plast Surg 1999;42:376
23. Guerrerosantos J. Autologous fat grafting for body contouring. Clin Plast Surg 1996;23:619
24. Roberts TL III, Weinfeld AB, Bruner TW, et al. Universal and ethnic ideals of beautiful buttocks are best obtained by autologous micro fat grafting and liposuction. Clin Plast Surg 2006;33:371
25. Billings E Jr, May J Jr. Historical review and present status of free graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 1989;83:368
26. Sommer B, Sattler G. Current concepts of fat graft survival: histology of aspirated adipose tissue and review of the literature. Dermatol Surg 2000;26:1159
27. Coleman SR. Structural fat grafts. Clin Plast Surg 2001;28:111
28. Guyuron B, Majzoub RK. Facial augmentation with core fat graft: a preliminary report. Plast Reconstr Surg 2007;120:295
29. Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg 2006;118:1088
30. Guallar JP, Gallego-Escuredo JM, Domingo JC, et al. Differential gene expression indicates that "buffalo hump" is a distinct adipose tissue disturbance in HIV-1 associated lipodystrophy. AIDS 2008;22: 575-584 (Pubitemid 351640590)